Skip to main content
. Author manuscript; available in PMC: 2025 Mar 4.
Published in final edited form as: Expert Opin Drug Metab Toxicol. 2024 Mar 4;20(1-2):73–93. doi: 10.1080/17425255.2024.2309213

Table 4.

Summary of in vitro induction studies with pregnancy hormones for CYPs and UGTs involved in THC, 11-OH-THC, and 11-COOH-THC clearance.

Target Enzyme Hormone Change References

CYP2C9 Estradiol Increase in activity but no change in expression [147]
CYP2C9 Cortisol Evidence of GR response element [148]
CYP3A4 Growth hormones No change in activity or expression and an increase in expression [149,150]
CYP3A4 Progesterone Increase in expression and activity and no change in expression/activity [147,149]
CYP3A4 Estradiol Increase in expression and activity and no change in expression/activity [147,149]
CYP3A4 Cortisol Increased expression and activity [149,151]
UGT1A1 Progesterone Increased expression [152]
UGT1A1 Estradiol Increased expression [153]
UGT1A1 Cortisol No change in expression [153]
UGT1A4 Estradiol Increased expression [153]
UGT1A9 Estradiol Increased expression [154]
UGT2B7 Estradiol, estriol, estetrol, progesterone, and cortisol No change in expression [152,153]

CYP: cytochrome P450; UGT: uridine 5’-diphospho-glucuronosyltransferases; GR: glucocorticoid receptor.